Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the product. Protect from freezing.
Rx only 250 mL
Intended for use only with automated apheresis devices.
Each 100 mL contains:
Sodium Citrate (Dihydrate), USP 4.0 g
(pH adjusted with Citric Acid, Monohydrate, USP)
Not for direct intravenous infusion. The pouch is a moisture barrier. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion.
STERILE, nonpyrogenic fluid path.
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the product. Protect from freezing.
Laboratorios Grifols, S. A.
SPAIN
Revision: 10/2019
NDC 76297-006-04
Anticoagulant Sodium Citrate 4% w/v
Solution, USP 250 mL
Rx Only
Intended for use only with automated apheresis devices.
Not for direct intravenous infusion.
RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions permitted
between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].
Brief exposure up to 40°C (104°F) does not adversely affect the product.
Protect from freezing.
LOT XXXXXX EXP YYYY-MM
39 x 250 mL
Num.:
GRIFOLS
Laboratorios Grifols, S. A. SPAIN
LOT: XXXXXX EXP: YYYY-MM
NDC 76297-006-02
Anticoagulant Sodium Citrate 4% w/v
Solution, USP 250 mL
Rx Only
Intended for use only with automated apheresis devices
Each 100 mL contains:
Sodium Citrate (Dihydrate), USP 4.0 g
(pH adjusted with Citric Acid, Monohydrate, USP)
Caution: Not for direct intravenous infusion. The pouch is a moisture barrier.
Do not use unless solution is clear and no leaks detected. Single use container.
Discard unused portion.
STERILE, nonpyrogenic fluid path.
RECOMMENDED STORAGE: Store at 20° to 25°C (68° to 77°F); excursions
permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room
Temperature]. Brief exposure up to 40°C (104°F) does not adversely affect the
product. Protect from freezing.
Laboratorios Grifols, S. A. SPAIN
GRIFOLS
| Class | Version | Type | Effective |
|---|---|---|---|
| ANHYDROUS CITRIC ACID Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Data Matrix | 4000601 | Container label.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76297-006-02 | Anticoagulant Sodium Citrate | 250 mL in 1 BAG | SOLUTION | 250 | 7 | |
| 76297-006-03 | Anticoagulant Sodium Citrate | 30 in 1 CARTON | SOLUTION | 30 | 7 | |
| 76297-006-04 | Anticoagulant Sodium Citrate | 39 in 1 CARTON | SOLUTION | 39 | 7 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76297-006 | 76297-006-02, 76297-006-03, 76297-006-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Trisodium Citrate Dihydrate | B22547B95K | ACTIM |
| Water | 059QF0KO0R | IACT |
| Citric Acid Monohydrate | 2968PHW8QP | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anticoagulant Sodium Citrate | TRISODIUM CITRATE DIHYDRATE | LABORATORIOS GRIFOLS SA | db8334be-5b8b-4811-811a-efbe32b6d147 | 2026-04-14 | Warnings | 76297-006-04 76297-006-03 76297-006-02 76297-006 76297000604 76297000603 76297000602 fa83d193-9cfc-40c0-b924-b1685c50d08a db8334be-5b8b-4811-811a-efbe32b6d147 |
Adverse event summaries are temporarily unavailable. Other product information remains available.